Advanced Robotic Training With Additional Degrees of Freedom: Towards a Free-walking System
NCT ID: NCT02189551
Last Updated: 2018-08-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
9 participants
INTERVENTIONAL
2014-06-30
2015-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Primary study endpoints will be a significantly higher rated patient comfort and or patient satisfaction using the new versions, compared with the established Lokomat. Furthermore, muscle activity and kinematic movement patterns will be expected to show more involved muscle groups and a walking pattern involving more degrees of freedom during use of the new version compared with the established Lokomat.
Exploratory endpoints will be a significantly stronger involvement of muscles needed for balance, more physiological walking patterns and more change on the lateral positioning of the feet due to training with the new version, compared with the established Lokomat.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of a Training in the Walking With Exosquelette
NCT02085954
Validation of a Novel Robot-aided Assessment of Gait Ability
NCT02425332
Robot-Assisted Gait Training in Early-Subacute Stroke
NCT06233734
Robotic Assessment of Lower Extremity Motor Learning
NCT01361867
Gait Training for Persons With Stroke
NCT00612300
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lokomat Pro
gait robot established on the market
Gait training with Lokomat Pro
Lokomat Pro FreeD
gait robot based on the Lokomat Pro with changes in guidance of the hip, approved for the Swiss market
Gait training with Lokomat Pro FreeD
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Gait training with Lokomat Pro
Gait training with Lokomat Pro FreeD
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* minor functional impairment (MRC \< 5)
* ability and willingness to participate
Exclusion Criteria
* severe dementia
* severe depression
* any other contraindications against Lokomat training
* body weight \> 135 kg
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Swiss Commission for Technology and Innovation
OTHER
Swiss Federal Institute of Technology
OTHER
Hocoma AG
UNKNOWN
University of Zurich
OTHER
Cereneo AG
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cereneo, Center For Rehabilitation and Neurology
Vitznau, Canton of Lucerne, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EKNZ: 2014-052
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.